Current Liabilities
Other Commercial Liabilities
Procter & Gamble Other Commercial Liabilities decreased by 4.1% to $10.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.9%, from $9.85B to $10.03B. Over 4 years (FY 2021 to FY 2025), Other Commercial Liabilities shows relatively stable performance with a 1.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2015
Last reportedQ3 2026Apr 24, 2026
Metric ID:
commercial_liabilities_otherHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.52B | $10.38B | $10.54B | $10.32B | $9.55B | $10.06B | $10.29B | $10.52B | $10.93B | $10.91B | $11.10B | $10.92B | $11.07B | $10.66B | $9.88B | $9.85B | $11.32B | $10.76B | $10.46B | $10.03B |
| QoQ Change | — | -1.4% | +1.6% | -2.1% | -7.5% | +5.3% | +2.4% | +2.2% | +3.9% | -0.2% | +1.7% | -1.6% | +1.4% | -3.7% | -7.3% | -0.3% | +14.9% | -5.0% | -2.7% | -4.1% |
| YoY Change | — | — | — | — | -9.2% | -3.1% | -2.4% | +1.9% | +14.4% | +8.5% | +7.8% | +3.8% | +1.3% | -2.3% | -11.0% | -9.8% | +2.2% | +0.9% | +5.9% | +1.9% |
Range$9.55B – $11.32B
CAGR-1.0%
Avg YoY Growth+0.7%
Median YoY Growth+1.6%
Current Streak3 quarters decline
Other Commercial Liabilities at Other Companies
Frequently Asked Questions
- What is Procter & Gamble's other commercial liabilities?
- Procter & Gamble (PG) reported other commercial liabilities of $10.03B in Q1 2026.
- How has Procter & Gamble's other commercial liabilities changed year-over-year?
- Procter & Gamble's other commercial liabilities increased by 1.9% year-over-year, from $9.85B to $10.03B.
- What is the long-term trend for Procter & Gamble's other commercial liabilities?
- Over 4 years (2021 to 2025), Procter & Gamble's other commercial liabilities has grown at a 1.8% compound annual growth rate (CAGR), from $10.52B to $11.32B.